SCHEMBL4977192

SCHEMBL4977192

O=C(C1CCCO1)N1CCc2c(ncnc2N2CCN(C3CCC3)CC2)C1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 4/20 0.46
HSD17B10 Q99714 4/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.43
IRAK4 Q9NWZ3 1/20 0.41
GRM5 P41594 2/20 0.40
GPR6 P46095 4/20 0.39
HRH1 P35367 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
HPGD P15428 2/20 0.37
CASP1 P29466 2/20 0.37
NAMPT P43490 3/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
CASP7 P55210 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4974693 0.86 HRH3 (0.40) ALDH1A1HTTHRH1HRH3LMNA
SCHEMBL4978472 0.86 HRH3 (0.40) IRAK4GRM5HRH1HRH3
SCHEMBL4978437 0.85 HRH1 (0.42) ALDH1A1HTTIRAK4HRH1HRH3
SCHEMBL4980327 0.85 HRH1 (0.41) ALDH1A1KDM4EHTTGRM5HRH1
SCHEMBL4975425 0.85 HRH1 (0.41) ALDH1A1KDM4EHTTGRM5HRH1
SCHEMBL4974946 0.84 GRM5 (0.39) GRM5HRH1HRH3NAMPT
SCHEMBL4980362 0.81 HRH3 (0.39) ALDH1A1HTTGPR6HRH1HRH3
SCHEMBL4974700 0.81 TLR7 (0.40) ALDH1A1HTTGPR6HRH1HRH3
SCHEMBL4979872 0.79 ADORA2A (0.47) ALDH1A1KDM4EHSD17B10HTTIRAK4
SCHEMBL4980177 0.79 KCNK3 (0.49) ALDH1A1KDM4EHTTHRH1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
WO-2007146122-A2 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES HRH3, HRH4, HRH2 ALDH1A1 1142/4885KDM4E 1865/4885HSD17B10 4078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.